Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB18394InvestigationalProtein Based Therapies
Iodine I-124 Evuzamitide: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Transthyretin, Serum amyloid A-1 protein, and Leukocyte cell-derived chemotaxin-2
- Also known as
- 124I-p5+14 · Evuzamitide Iodine I-124 · Glycylglycylglycyl-3-(iodo-124I)-L-tyrosyl-L-seryl-L-lysyl-L-alanyl-L-glutaminyl-L-lysyl-L-alanyl-L-glutaminyl-L-alanyl-L-lysyl-L-glutaminyl-L-alanyl-L-lysyl-L-glutaminyl-L-alanyl-L-glutaminyl-L-lysyl-L-alanyl-L-glutaminyl-L-lysyl-L-alanyl-L-glutaminyl-L · Iodine (124i) evuzamitide · iodine (¹²⁴I) evuzamitide
- Code names
- APi1832 · AT-01 · IAT-01
Resolves to
Compound
What you can answer from here — as of July 09, 2026
Which drugs share a target with Iodine I-124 Evuzamitide, and which of those have an active Phase 3 trial?